Citation Tools
Commentary: General medicine
Ocrelizumab appears to reduce relapse and disability in multiple sclerosis but quality of evidence is moderate
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Ocrelizumab appears to reduce relapse and disability in multiple sclerosis but quality of evidence is moderate